投資評等
最後更新日期:2024/11/26
升級(Upgrade)
日期/Date | 券商 Brokerage Firm | 原評等->升級後評等 Upgrade from: -> to: | 新目標價 New Target |
2015/1/5 | Oppenheimer | Perform >> Outperform | 160 |
2013/7/1 | Needham | Hold >> Buy | 85 |
2013/4/2 | Robert W. Baird | Neutral >> Outperform | |
2012/4/19 | Capstone Investments | Hold >> Buy | $136 >> $149 |
2012/4/19 | Wunderlich | Hold >> Buy | $120 >> $145 |
2011/12/20 | Oppenheimer | Perform >> Outperform | 125 |
2011/10/26 | MKM Partners | Neutral >> Buy | $90 >> $120 |
2011/8/25 | McAdams Wright Ragen | Hold >> Buy | $120 >> $100 |
2011/8/25 | Stifel Nicolaus | Hold >> Buy | 84 |
2011/6/22 | Barclays Capital | Equal Weight >> Overweight | $110 >> $125 |
2010/7/22 | RBC Capital Mkts | Sector Perform >> Outperform | $70 >> $90 |
2010/2/5 | Wedbush Morgan | Neutral >> Outperform | 60 |
2010/1/21 | Broadpoint AmTech Research | Neutral >> Buy | $37 >> $63 |
2009/10/22 | MKM Partners | Neutral >> Buy | 50 |
2009/10/22 | Canaccord Adams | Hold >> Buy | |
2009/10/22 | UBS | Sell >> Neutral | |
2006/6/19 | Robert W. Baird | Neutral Outperform | 57 |
2006/5/26 | Matrix Research | Sell Hold | |
2006/5/22 | Harris Nesbitt | Neutral Outperform | 65 |
2005/8/17 | Janney Mntgmy Scott | Neutral->Buy | |
2005/8/8 | Kaufman Bros | Hold->Buy | 49 |
2004/3/30 | Adams Harkness | Buy->Strong Buy | 43 |
2004/3/22 | JMP Securities | Mkt Outperform->Strong Buy | |
2004/3/2 | Oppenheimer | Neutral->Buy | |
2003/10/30 | First Albany | Neutral -> Buy | 30 |
2003/10/3 | JMP Securities | Mkt Perform -> Mkt Outperform | |
2003/1/23 | Pacific Growth Equities | Equal Weight -> Over Weight | |
2003/1/23 | Salomon Smth Brny | In-line -> Outperform | 16 |
降級(Downgrade)
日期/Date | 券商 Brokerage Firm | 原評等->降級後評等 Upgrade from: -> to: | 新目標價 New Target |
2015/11/13 | Dougherty & Company | Buy >> Neutral | |
2015/8/3 | Buckingham Research | Buy >> Neutral | |
2015/3/9 | Barclays | Equal Weight >> Underweight | 114 |
2013/1/22 | Needham | Buy >> Hold | |
2012/10/5 | Barclays | Overweight >> Equal Weight | $115 >> $105 |
2010/10/22 | Barclays Capital | Overweight >> Equal Weight | $90 >> $95 |
2009/12/11 | William Blair | Outperform >> Mkt Perform | |
2009/11/20 | Auriga U.S.A | Buy >> Hold | 48 |
2009/10/16 | Oppenheimer | Outperform >> Perform | |
2009/5/21 | RBC Capital Mkts | Outperform >> Sector Perform | |
2009/5/18 | Stifel Nicolaus | Buy Hold | |
2009/4/23 | Noble Financial | Hold Sell | |
2009/4/23 | UBS | Neutral Sell | |
2009/4/13 | McAdams Wright Ragen | Buy Hold | |
2009/1/16 | UBS | Buy Neutral | |
2006/11/10 | Citigroup | Buy Hold | |
2006/7/21 | Kaufman Bros | Buy Hold | |
2005/12/7 | Robert W. Baird | Outperform->Neutral | |
2005/11/18 | Citigroup | Buy->Hold | |
2005/3/14 | Pacific Crest | Outperform->Sector Perform | |
2005/2/15 | JMP Securities | Strong Buy->Mkt Outperform | |
2004/12/9 | Adams Harkness | Strong Buy->Buy | |
2004/11/17 | Deutsche Securities | Buy->Hold | |
2004/4/2 | Merrill Lynch | Buy->Neutral | |
2004/2/2 | Oppenheimer | Buy->Neutral | |
2002/10/30 | Wedbush Morgan | Buy -> Hold | |
首次予以評等(Coverage Initiated)
日期/Date | 券商 Brokerage Firm | 原評等->升級後評等 Upgrade from: -> to: | 目標股價 |
2014/2/10 | Dougherty & Company | Buy | 125 |
2011/11/2 | JMP Securities | Mkt Outperform | 140 |
2011/1/6 | Wunderlich | Hold | 139 |
2009/10/13 | Auriga U.S.A | Buy | 48 |
2009/9/9 | Boenning & Scattergood | Outperform | 45 |
2009/7/31 | BMO Capital Markets | Market Perform | 36 |
2009/7/2 | Deutsche Securities | Hold | 37 |
2009/6/18 | Morgan Keegan | Mkt Perform | |
2009/4/14 | AmTech Research | Neutral | |
2009/4/8 | Brean Murray | Buy | 27 |
恢復投資評等(Coverage Resumed)
日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
2012/1/6 | Morgan Keegan | Outperform | 126 |
2003/12/11 | Merrill Lynch | Buy | 30 |
重申相同投資評等(Coverage Reiterated)
日期/Date | 券商 Brokerage Firm | 重申相同投資評等 Reiterated Rating | 新目標價 New Target |
2013/7/25 | Deutsche Bank | Buy | $100 >> $93 |
2012/7/19 | UBS | Neutral | $120 >> $110 |
2012/7/2 | Northland Securities | Market Perform | $134 >> $120 |
2012/7/2 | Oppenheimer | Outperform | $150 >> $130 |
2012/5/31 | UBS | Neutral | $140 >> $120 |
2012/4/19 | UBS | Neutral | $127 >> $140 |
2012/3/5 | UBS | Neutral | $110 >> $127 |
2012/1/19 | Barclays Capital | Overweight | $125 >> $135 |
2011/11/14 | Deutsche Bank | Buy | $110 >> $125 |
2011/11/7 | McAdams Wright Ragen | Buy | $110 >> $125 |